Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives

SIMPLE SUMMARY: Colorectal cancer is one of the leading causes of cancer-associated deaths worldwide. From the 1960s to 2002, the standard systemic treatment consisted of cytotoxic chemotherapy. However, in the past 20 years, the development of targeted therapies has revolutionized care for CRC. Doz...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzi, Joao, Hoff, Camilla O., Ferreira, Raphaella, Pimentel, Agustin, Datta, Jashodeep, Livingstone, Alan S., Vianna, Rodrigo, Abreu, Phillipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252368/
https://www.ncbi.nlm.nih.gov/pubmed/37296986
http://dx.doi.org/10.3390/cancers15113023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252368/
https://www.ncbi.nlm.nih.gov/pubmed/37296986
http://dx.doi.org/10.3390/cancers15113023

Ejemplares similares